Found: 73
Select item for more details and to access through your institution.
Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 6, p. 2345, doi. 10.1007/s00432-023-04590-9
- By:
- Publication type:
- Article
Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 7, p. 1703, doi. 10.1007/s00432-021-03911-0
- By:
- Publication type:
- Article
Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Racial Differences in Cutaneous Events Among Patients Receiving Enfortumab Vedotin.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 3, p. N.PAG, doi. 10.1016/j.clgc.2024.102090
- By:
- Publication type:
- Article
Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1--positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 1, p. e17, doi. 10.1016/j.clgc.2020.07.006
- By:
- Publication type:
- Article
Temporal changes in treatment patterns by age group and functional status before and after PD-1/L1 inhibitor approvals in advanced urothelial carcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1210208
- By:
- Publication type:
- Article
Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2016, v. 23, n. 9, p. 2936, doi. 10.1245/s10434-016-5224-1
- By:
- Publication type:
- Article
Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, p. 863, doi. 10.1245/s10434-015-4677-y
- By:
- Publication type:
- Article
Posttraumatic Stress Disorder and Cancer Risk: A Nested Case-Control Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 3, p. 1084, doi. 10.4143/crt.2015.405
- By:
- Publication type:
- Article
Digoxin use is associated with pancreatic cancer risk but does not affect survival.
- Published in:
- Cancer Causes & Control, 2021, v. 32, n. 1, p. 41, doi. 10.1007/s10552-020-01352-7
- By:
- Publication type:
- Article
An association between newly diagnosed cutaneous T cell lymphoma and prior impetigo: a nested case-control study.
- Published in:
- Archives of Dermatological Research, 2016, v. 308, n. 9, p. 661, doi. 10.1007/s00403-016-1684-1
- By:
- Publication type:
- Article
Accuracy of a Text Intervention to Minimize the Burden of Cancer Care Among Patients Treated With Immune Checkpoint Inhibitors.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 9, p. e2228452, doi. 10.1001/jamanetworkopen.2022.28452
- By:
- Publication type:
- Article
Outcomes Among African American and Non-Hispanic White Men With Metastatic Castration-Resistant Prostate Cancer With First-Line Abiraterone.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 1, p. e2142093, doi. 10.1001/jamanetworkopen.2021.42093
- By:
- Publication type:
- Article
Impact of Label Restriction on Checkpoint-Inhibitor Use in Bladder Cancer and Changes in Mortality.
- Published in:
- JNCI Cancer Spectrum, 2022, v. 6, n. 4, p. 1, doi. 10.1093/jncics/pkac050
- By:
- Publication type:
- Article
Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 2, p. 1, doi. 10.1093/jncics/pkaa121
- By:
- Publication type:
- Article
Meta-Analysis of Age, Sex, and Race Disparities in the Era of Contemporary Urothelial Carcinoma Treatment.
- Published in:
- Cancers, 2024, v. 16, n. 19, p. 3338, doi. 10.3390/cancers16193338
- By:
- Publication type:
- Article
The effect of past antibiotic exposure on diabetes risk.
- Published in:
- European Journal of Endocrinology, 2015, v. 172, n. 6, p. 639, doi. 10.1530/EJE-14-1163
- By:
- Publication type:
- Article
Comparing survival in trial‐ versus routine‐care advanced urothelial cancer patients on immune checkpoint blockade.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5798
- By:
- Publication type:
- Article
Very high PD‐L1 expression as a prognostic indicator of overall survival among patients with advanced non‐small cell lung cancer receiving anti‐PD‐(L)1 monotherapies in routine practice.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 10, p. 1121, doi. 10.1002/pds.5487
- By:
- Publication type:
- Article
'Considering the totality of evidence: Combining real‐world data with clinical trial results to better inform decision‐making.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 6, p. 814, doi. 10.1002/pds.5218
- By:
- Publication type:
- Article
Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2345013, doi. 10.1001/jamanetworkopen.2023.45013
- By:
- Publication type:
- Article
Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e238395, doi. 10.1001/jamanetworkopen.2023.8395
- By:
- Publication type:
- Article
Medication class enrichment analysis: a novel algorithm to analyze multiple pharmacologic exposures simultaneously using electronic health record data.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 8, p. 3698, doi. 10.1002/cam4.2102
- By:
- Publication type:
- Article
Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta‐Analysis.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 2, p. 260, doi. 10.1002/acr.24784
- By:
- Publication type:
- Article
Salivary cotinine level and treatment response in muscle invasive bladder cancer: A pilot study.
- Published in:
- BJUI Compass, 2023, v. 4, n. 2, p. 164, doi. 10.1002/bco2.204
- By:
- Publication type:
- Article
Association of Medicaid Expansion Under the Affordable Care Act With Insurance Status, Cancer Stage, and Timely Treatment Among Patients With Breast, Colon, and Lung Cancer.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 2, p. e1921653, doi. 10.1001/jamanetworkopen.2019.21653
- By:
- Publication type:
- Article
A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data.
- Published in:
- Pragmatic & Observational Research, 2017, v. 8, p. 149, doi. 10.2147/POR.S140579
- By:
- Publication type:
- Article
Comparative Effectiveness of Total Neoadjuvant Therapy Versus Standard Adjuvant Chemotherapy for Locally Advanced Rectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Postoperative Radiation for Pathologic Stage T4 Colon Cancers Receiving Adjuvant Chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Risk Prediction Model for Sporadic CRC Based on Routine Lab Results.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Low- vs High-Dose 5-FU in Triplet Chemotherapy Plus Bevacizumab for Patients With Colorectal Cancer.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 7, p. e2424855, doi. 10.1001/jamanetworkopen.2024.24855
- By:
- Publication type:
- Article
Antibiotics and Obesity--A Burgeoning or Thinning Argument?
- Published in:
- JAMA Pediatrics, 2017, v. 171, n. 2, p. 118, doi. 10.1001/jamapediatrics.2016.4032
- By:
- Publication type:
- Article
Comparison of the 'iROC' trial participants to patients with bladder cancer in the United States undergoing radical cystectomy.
- Published in:
- BJU International, 2023, v. 131, n. 4, p. 439, doi. 10.1111/bju.15954
- By:
- Publication type:
- Article
Association Between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Assessing the effects of beta‐blockers on pancreatic cancer risk: A nested case‐control study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 5, p. 599, doi. 10.1002/pds.4993
- By:
- Publication type:
- Article
Ion channel blockers and glioblastoma risk and outcome: a nested case-control and retrospective cohort studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 10, p. 1179, doi. 10.1002/pds.4054
- By:
- Publication type:
- Article
Increasing use of prescription drugs in the United Kingdom.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 6, p. 628, doi. 10.1002/pds.3947
- By:
- Publication type:
- Article
Validation of a coding algorithm for intra-abdominal surgeries and adhesion-related complications in an electronic medical records database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 4, p. 405, doi. 10.1002/pds.3974
- By:
- Publication type:
- Article
Impact of antibiotic exposure on the risk of colorectal cancer.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 5, p. 534, doi. 10.1002/pds.3765
- By:
- Publication type:
- Article
Digoxin use and the risk for colorectal cancer.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 11, p. 1147, doi. 10.1002/pds.3717
- By:
- Publication type:
- Article
Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 6, p. 636, doi. 10.1002/pds.3619
- By:
- Publication type:
- Article
Distinguishing incident and prevalent diabetes in an electronic medical records database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 2, p. 111, doi. 10.1002/pds.3557
- By:
- Publication type:
- Article
Reappraisal of risk factors for monoclonal gammopathy of undetermined significance.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 581, doi. 10.1002/ajh.24355
- By:
- Publication type:
- Article
Association Between Statin Use at the Time of Intra-abdominal Surgery and Postoperative Adhesion-Related Complications and Small-Bowel Obstruction.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 2, p. e2036315, doi. 10.1001/jamanetworkopen.2020.36315
- By:
- Publication type:
- Article
Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 10, p. e2018318, doi. 10.1001/jamanetworkopen.2020.18318
- By:
- Publication type:
- Article
Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 10, p. 2403, doi. 10.1002/art.39738
- By:
- Publication type:
- Article